chr12-132676209-CC-TG
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_006231.4(POLE):c.910-6_910-5delGGinsCA variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006231.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The c.910-6_910-5delGGinsCA intronic variant, located in intron 9 of the POLE gene, results from the deletion of two nucleotides (GG) and the insertion of two nucleotides (CA) at nucleotide positions c.910-6 to c.910-5. These nucleotide positions are poorly conserved in available vertebrate species. Using the Human Splicing Finder (HSF) and MaxEntScan splice site prediction tools, this alteration is not predicted to have any significant effect on this splice acceptor site; however, direct evidence is unavailable (Desmet FO et al. Nucleic Acids Res., 2009 May;37:e67). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at